Contract with Customer, Liability, Current in USD of Bionik Laboratories Corp. from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Bionik Laboratories Corp. quarterly Contract with Customer, Liability, Current history and change rate from Q1 2019 to Q1 2023.
  • Bionik Laboratories Corp. Contract with Customer, Liability, Current for the quarter ending 31 Mar 2023 was $342K, a 9.08% increase year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Bionik Laboratories Corp. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $342K +$28.5K +9.08% 31 Mar 2023 10-K 21 Jun 2023
Q4 2022 $397K +$98K +32.8% 31 Dec 2022 10-Q 08 Feb 2023
Q3 2022 $453K +$258K +132% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $247K +$14.5K +6.26% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $314K +$45.8K +17.1% 31 Mar 2022 10-K 21 Jun 2023
Q4 2021 $299K -$2.63K -0.87% 31 Dec 2021 10-Q 09 Feb 2022
Q3 2021 $195K -$331K -62.9% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $232K -$350K -60.1% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $268K +$67.6K +33.7% 31 Mar 2021 10-K 09 Jun 2022
Q4 2020 $301K -$376K -55.5% 31 Dec 2020 10-Q 11 Feb 2021
Q3 2020 $526K -$64.3K -10.9% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 $582K 30 Jun 2020 10-Q 12 Aug 2020
Q1 2020 $200K -$267K -57.2% 31 Mar 2020 10-K 24 Jun 2021
Q4 2019 $678K 31 Dec 2019 10-Q 14 Feb 2020
Q3 2019 $591K 30 Sep 2019 10-Q 14 Nov 2019
Q1 2019 $468K 31 Mar 2019 10-K 29 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.